← back to search

Mary Motyl

Merck & Co., Inc., Rahway, NJ, USA (United States) · US
Area of research
Molecular Medicine · Pharmacology
Research interest
Research interests include Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance, and Nosocomial Infections in ICU.
h-index
42
citations
6,620
works
187
NIH funding
primary concept
email

Recent publications

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
The Lancet 2021cited by 272position: middledoi
Predicting Antibiotic Resistance in Gram-Negative Bacilli from Resistance Genes
Antimicrobial Agents and Chemotherapy 2019cited by 28position: middledoi
Genomic Epidemiology of Global Carbapenemase-Producing<i>Enterobacter</i>spp., 2008–2014
Emerging infectious diseases 2018cited by 152position: middledoi
Global<i>Escherichia coli</i>Sequence Type 131 Clade with<i>bla</i><sub>CTX-M-27</sub>Gene
Emerging infectious diseases 2016cited by 174position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yasufumi Matsumura · Kyoto University2 papers (2016–2018)Gisele Peirano · University of Calgary2 papers (2016–2018)Johann Pitout · Alberta Health Services2 papers (2016–2018)Patricia A. Bradford · Inorganic Specialists (United States)2 papers (2016–2018)Liang Chen · South China Agricultural University1 papers (2018–2018)Michio Tanaka · Kyoto University1 papers (2016–2016) · 1 papers (2021–2021) · 1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019)Satoshi Ichiyama · Kyoto University1 papers (2016–2016)Shariq Haider · McMaster University1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Meinolf Karthaus · München Klinik1 papers (2021–2021)Ryota Gomi · Kyoto University1 papers (2016–2016) · 1 papers (2021–2021) · 1 papers (2019–2019)Shunji Takakura · National Center for Global Health and Medicine1 papers (2016–2016)Miki Nagao · Kyoto University1 papers (2016–2016)